CRH Public Ltd Co (CRH) stock
Close on Oct 29, 2026Market cap $60.29BP/E 17.0Yield 1.63%
Earnings
CRH Public's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of CRH Public's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 17, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026before the open | $11.40B | +2.7% | $1.86 | $2.09 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026before the open | $10.80B | +5.9% | $2.21 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026before the open | $7.40B | +8.8% | -$0.27 | -$0.20 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 18, 2026after the close | $9.42B | +5.8% | $1.52 | $1.52 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025after the close | $11.10B | +5.6% | $2.21 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $10.20B | +5.2% | $1.94 | $1.94 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 5, 2025after the close | $6.80B | +4.6% | -$0.15 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025after the close | $8.90B | -74.5% | $1.02 | $1.45 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | $10.52B | – | $1.97 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $9.70B | – | $1.88 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 10, 2024before the open | $6.50B | – | $0.16 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 29, 2024before the open | $34.90B | – | $4.36 | $4.65 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
CRH Public's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted EBITDA*non-GAAP | FY2026 | $7.80B – $8.00B | – | New | Oct 29, 2026 |
| Adjusted EBITDA*non-GAAP | FY2026 | $8.10B – $8.50B | $8.10B – $8.50B | Reaffirmed | Jul 30, 2026 |
| Diluted EPS | FY2026 | $5.60 – $6.05 | $5.60 – $6.05 | Reaffirmed | Jul 30, 2026 |
| Diluted EPSGAAP | FY2026 | $5.60 – $6.05 | – | New | Feb 18, 2026 |
| Diluted EPS (ii)GAAP | FY2026 | $4.63 – $4.85 | – | New | Oct 29, 2026 |
| Adjusted Diluted EPS* (iii)non-GAAP | FY2026 | $5.37 – $5.59 | – | New | Oct 29, 2026 |
| Capital expenditure | FY2026 | $2.60B – $2.80B | – | New | Oct 29, 2026 |
| Capital expenditure | FY2026 | $2.70B – $2.90B | $2.80B – $3.00B | Lowered | Jul 30, 2026 |
| Net income | FY2026 | $3.90B – $4.10B | $3.90B – $4.10B | Reaffirmed | Jul 30, 2026 |
| Net incomeGAAP | FY2026 | $3.90B – $4.10B | – | New | Feb 18, 2026 |
| Net income (ii)GAAP | FY2026 | $3.10B – $3.30B | – | New | Oct 29, 2026 |
Guidance vs results
The last range CRH Public gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | EPS (GAAP) | $5.49 – $5.72 | $5.52Σ4Q | Within range |
Guidance history
Every forecast CRH Public put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Capital expenditure | FY2026 | $2.60B – $2.80B | New |
| Oct 29, 2026 | Adjusted EBITDA* | FY2026 | $7.80B – $8.00B | New |
| Oct 29, 2026 | Adjusted Diluted EPS* (iii) | FY2026 | $5.37 – $5.59 | New |
| Oct 29, 2026 | Diluted EPS (ii) | FY2026 | $4.63 – $4.85 | New |
| Oct 29, 2026 | Net income (ii) | FY2026 | $3.10B – $3.30B | New |
| Jul 30, 2026 | Capital expenditure | FY2026 | $2.70B – $2.90B | Lowered |
| Jul 30, 2026 | Adjusted EBITDA* | FY2026 | $8.10B – $8.50B | Reaffirmed |
| Jul 30, 2026 | Diluted EPS | FY2026 | $5.60 – $6.05 | Reaffirmed |
| Jul 30, 2026 | Net income | FY2026 | $3.90B – $4.10B | Reaffirmed |
| Apr 30, 2026 | Capital expenditure | FY2026 | $2.80B – $3.00B | Reaffirmed |
| Apr 30, 2026 | Adjusted EBITDA* | FY2026 | $8.10B – $8.50B | Reaffirmed |
| Apr 30, 2026 | Diluted EPS | FY2026 | $5.60 – $6.05 | New |
| Apr 30, 2026 | Net income | FY2026 | $3.90B – $4.10B | New |
| Feb 18, 2026 | Capital expenditure | FY2026 | $2.80B – $3.00B | New |
| Feb 18, 2026 | Adjusted EBITDA* | FY2026 | $8.10B – $8.50B | New |
| Feb 18, 2026 | Diluted EPS | FY2026 | $5.60 – $6.05 | New |
| Feb 18, 2026 | Net income | FY2026 | $3.90B – $4.10B | New |
| Nov 5, 2025 | Capital expenditure | FY2025 | $2.70B – $2.80B | New |
| Nov 5, 2025 | Adjusted EBITDA* | FY2025 | $7.60B – $7.70B | New |
| Nov 5, 2025 | Diluted EPS (ii) | FY2025 | $5.49 – $5.72 | New |
| Nov 5, 2025 | Net income | FY2025 | $3.80B – $3.90B | New |
| May 5, 2025 | Capital expenditure | FY2025 | $2.80B – $3.00B | Reaffirmed |
| May 5, 2025 | Adjusted EBITDA* | FY2025 | $7.30B – $7.70B | Reaffirmed |
| May 5, 2025 | Diluted earnings per share | FY2025 | $5.34 – $5.80 | New |
| May 5, 2025 | Net income | FY2025 | $3.70B – $4.10B | New |
| Feb 26, 2025 | Capital expenditure | FY2025 | $2.80B – $3.00B | New |
| Feb 26, 2025 | Adjusted EBITDA* | FY2025 | $7.30B – $7.70B | New |
| Feb 26, 2025 | Diluted EPS (ii) | FY2025 | $5.34 – $5.80 | New |
| Feb 26, 2025 | Net income | FY2025 | $3.70B – $4.10B | New |
| Nov 7, 2024 | Capital expenditure | FY2024 | $2.40B – $2.60B | Raised |
| Nov 7, 2024 | Adjusted EBITDA* | FY2024 | $6.87B – $6.97B | Narrowed |
| Nov 7, 2024 | EPS | FY2024 | $5.45 – $5.55 | New |
| Nov 7, 2024 | Net income | FY2024 | $3.78B – $3.85B | New |
| Aug 8, 2024 | Capital expenditure | FY2024 | $2.20B – $2.40B | Reaffirmed |
| Aug 8, 2024 | Adjusted EBITDA* | FY2024 | $6.82B – $7.02B | Raised |
| Aug 8, 2024 | EPS | FY2024 | $5.40 – $5.60 | Raised |
| Aug 8, 2024 | Net income | FY2024 | $3.70B – $3.85B | Raised |
| May 10, 2024 | Capital expenditure | FY2024 | $2.20B – $2.40B | Reaffirmed |
| May 10, 2024 | Adjusted EBITDA | FY2024 | $6.55B – $6.85B | Reaffirmed |
| May 10, 2024 | EPS | FY2024 | $5.15 – $5.45 | Reaffirmed |
| May 10, 2024 | Net income | FY2024 | $3.55B – $3.80B | Reaffirmed |
| Feb 29, 2024 | Capital expenditure | FY2024 | $2.20B – $2.40B | New |
| Feb 29, 2024 | Adjusted EBITDA* | FY2024 | $6.55B – $6.85B | New |
| Feb 29, 2024 | EPS (i) | FY2024 | $5.15 – $5.45 | New |
| Feb 29, 2024 | Net income | FY2024 | $3.55B – $3.80B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases CRH Public filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Update